Identification of Key Genes and Pathways in Gefitinib-Resistant Lung Adenocarcinoma using Bioinformatics Analysis

Gefitinib resistance is a serious threat in the treatment of patients with non-small cell lung cancer (NSCLC). Elucidating the underlying mechanisms and developing effective therapies to overcome gefitinib resistance is urgently needed. The differentially expressed genes (DEGs) were screened from th...

Descripción completa

Detalles Bibliográficos
Autores principales: Mao, Kailin, Lin, Fang, Zhang, Yingai, Zhou, Hailong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8202261/
https://www.ncbi.nlm.nih.gov/pubmed/34177255
http://dx.doi.org/10.1177/11769343211023767

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8202261/
https://www.ncbi.nlm.nih.gov/pubmed/34177255
http://dx.doi.org/10.1177/11769343211023767

Ejemplares similares